Financial Data and Key Metrics Changes - IDEX delivered better-than-expected Q4 results with organic revenue growth of 1% and adjusted EBITDA margin expanding by 40 basis points year-over-year [16][17] - Free cash flow for the full year 2025 was $617 million, a 2% increase compared to the previous year, with a free cash flow conversion rate of 103% of adjusted net income [19][23] - Adjusted EPS for Q4 came in higher than the guided range, reflecting strong performance across segments [16][17] Business Line Data and Key Metrics Changes - Health & Science Technologies (HST) segment saw organic orders increase by 34% and revenue grow by 5%, driven by demand in data center applications and semiconductor consumables [12][20] - Fluid & Metering Technologies (FMT) reported organic orders growth of 4% and organic sales growth of 1%, with strong performance in municipal water and mining sectors [13][20] - Fire & Safety / Diversified Products (FSDP) experienced flat organic orders and a 5% decline in organic sales, impacted by external pressures outside the U.S. [15][22] Market Data and Key Metrics Changes - The municipal water-facing businesses within FMT grew mid-single digits, supported by increased capital spending on infrastructure refurbishment [90] - The industrial landscape remains flattish, with no significant signs of demand improvement, although there is an emerging consensus that 2026 may see a return to growth after three years of PMI contraction [14][15] - Demand in chemical, energy, and agriculture markets remains soft, contributing to challenges in FMT [21][22] Company Strategy and Development Direction - IDEX is focusing on a purposeful evolution, expanding capabilities in targeted advantage markets through organic growth and M&A, supported by their 80/20 playbook [7][28] - The company aims to leverage cross-business unit collaboration to drive growth and margin expansion, particularly within the HST segment [11][28] - M&A strategy will focus on integrating recently acquired businesses and pursuing bolt-on acquisitions, while maintaining a disciplined approach to capital allocation [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the macroeconomic environment, noting that while there are signs of improvement, they have not yet observed a significant inflection point in demand [15][36] - The outlook for 2026 includes expected organic growth of 1%-2%, with HST anticipated to grow mid-single digits, while FMT and FSDP are expected to remain flat to slightly down [25][26] - Management highlighted the importance of maintaining a strong balance sheet and disciplined capital allocation to support growth initiatives [23][24] Other Important Information - The company completed a small acquisition of Micro-LAM, which is expected to enhance their optics capabilities and contribute to growth in 2026 [10] - IDEX ended the year with strong liquidity of approximately $1.1 billion and repurchased nearly $250 million worth of shares in 2025 [19][23] Q&A Session Summary Question: Thoughts on demand outlook based on PMI data - Management noted that while they were pleased to see PMI above 50, they have not yet seen a corresponding inflection in demand across their businesses [34][36] Question: Fresh perspective on priorities from new CFO - The new CFO emphasized the strength of IDEX's franchise and the focus on M&A strategy and execution to drive growth [38][40] Question: Price contribution to top line in 2025 and outlook for 2026 - Price contributed around 3% to revenue in 2025, with expectations for a decrease to 0.0 to 0.2% in 2026 [45][46] Question: Disconnect between order strength and revenue conversion - Management explained that typical seasonal factors and larger orders from HST are contributing to the disconnect, with expectations for normalization in the coming quarters [54][56] Question: Insights on Life Sciences segment and growth expectations - The Life Sciences segment is expected to continue low single-digit growth, with some uncertainty due to external factors like government funding [60][61] Question: Order activity in HST and sustainability of growth - Management confirmed that January has shown strong order activity, indicating momentum beyond year-end budget spending [82] Question: Capital intensity for new markets like data centers - The capital intensity for new markets is expected to remain light, with opportunities to leverage existing equipment and resources [70][71]

Financial Data and Key Metrics Changes - IDEX delivered organic revenue growth of 1% in Q4 2025, with adjusted EBITDA margin expanding by 40 basis points year-over-year [16][19] - Free cash flow for the full year 2025 was $617 million, a 2% increase compared to the previous year, with a free cash flow conversion rate of 103% of adjusted net income [19][23] - Adjusted EPS for Q4 came in higher than the guided range, reflecting strong performance [16][19] Business Line Data and Key Metrics Changes - Health and Science Technology (HST) segment saw organic orders increase by 34% and revenue grow by 5%, driven by demand in data centers and semiconductor applications [12][20] - Fluid and Metering Technologies (FMT) experienced organic orders growth of 4% and organic sales growth of 1%, with strong performance in municipal water but softness in chemical and energy markets [13][20][21] - Fire and Safety Diversified Products (FSDP) had flat organic orders and a 5% decline in organic sales, with growth in North American fire OEM offset by weakness outside the U.S. [22] Market Data and Key Metrics Changes - The municipal water-facing businesses within FMT grew mid-single digits, supported by increased capital spending on infrastructure [90] - The general industrial landscape remains flattish, with no significant signs of demand improvement, although there is an emerging consensus that 2026 may see a return to growth [14][15] Company Strategy and Development Direction - IDEX is focusing on expanding and integrating capabilities in targeted advantage markets through its 80/20 playbook, which supports organic growth and M&A [7][29] - The company aims to maintain a balanced capital deployment strategy, focusing on organic investments, M&A, and returning capital to shareholders [23][24] Management's Comments on Operating Environment and Future Outlook - Management noted that while there are signs of order strength, particularly in HST, there has not yet been a clear inflection point in demand across all sectors [15][36] - The outlook for 2026 includes expected organic growth of 1%-2%, with mid-single-digit growth anticipated for HST and flat to slightly down outlooks for FMT and FSDP [25][26] Other Important Information - IDEX completed a small acquisition of Micro-LAM, which is expected to contribute positively to growth in 2026 [10] - The company ended 2025 with strong liquidity of approximately $1.1 billion and repurchased nearly $250 million worth of shares during the year [19][23] Q&A Session Summary Question: Demand outlook based on PMI and order size - Management acknowledged the recent PMI improvement but noted that they have not yet seen a corresponding inflection in demand, with steady order rates but no significant upward movement [34][35] Question: Fresh perspective on IDEX's operations - The new CFO highlighted the strong financial foundation of IDEX and expressed focus on M&A strategy and execution to drive growth [38][39] Question: Price contribution to top line growth - Price contributed approximately 3% to overall growth in 2025, with expectations for a decrease to 0.0% to 0.2% in 2026 [45][46] Question: Disconnect between order strength and revenue conversion - Management explained that while orders have been strong, revenue conversion may lag due to seasonal factors and the nature of longer-cycle applications [54][56] Question: Insights on life sciences segment - The life sciences segment experienced low single-digit growth, with expectations for normalization as government funding uncertainties resolve [60][61] Question: Order activity in municipal and industrial water - Management reported double-digit growth in municipal water orders in Q4, with confidence in sustainable mid-single-digit growth driven by critical infrastructure needs [90][91]

Financial Data and Key Metrics Changes - IDEX reported organic revenue growth of 1% in Q4 2025, with adjusted EBITDA margin expanding by 40 basis points year-over-year [15][18] - Free cash flow for the full year 2025 was $617 million, a 2% increase compared to the previous year, with a free cash flow conversion rate of 103% of adjusted net income [18][21] - Adjusted EPS for Q4 exceeded guidance, reflecting strong financial performance [15][18] Business Line Data and Key Metrics Changes - Health and Science Technology (HST) segment saw organic orders increase by 34% and revenue grow by 5%, driven by demand in data centers and semiconductor applications [19][12] - Fluid and Metering Technologies (FMT) reported organic orders growth of 4% and organic sales growth of 1%, with strong performance in municipal water but softness in chemical and agricultural markets [19][20] - Fire and Safety Diversified Products (FSDP) experienced flat organic orders and a 5% decline in organic sales, with growth in North America offset by weakness outside the U.S. [20][12] Market Data and Key Metrics Changes - The municipal water-facing businesses within FMT grew mid-single digits, supported by increased capital investment in infrastructure [90] - The general industrial landscape remains flattish, with expectations for a return to growth in 2026 after three years of PMI contraction [12][13] - Demand for precious metals in mining continues to be a strength for FMT [12] Company Strategy and Development Direction - IDEX is focusing on a strategic evolution through organic growth and M&A, leveraging its 80/20 playbook to optimize resources and drive growth in targeted markets [5][27] - The company aims to maintain a balanced capital deployment strategy, prioritizing organic investments, M&A, and returning capital to shareholders [21][23] - IDEX is committed to integrating recently acquired businesses and exploring bolt-on acquisitions to enhance its portfolio [23][24] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the macroeconomic environment, noting that while there are signs of potential growth, current indicators do not yet show a significant inflection point [12][13] - The company anticipates organic growth of 1%-2% for 2026, with mid-single digit growth expected for HST and flat to slightly down outlooks for FMT and FSDP [24][25] - Management highlighted the importance of maintaining operational excellence and leveraging growth opportunities in data centers and life sciences [12][19] Other Important Information - IDEX completed a small acquisition of Micro-LAM, which is expected to enhance its capabilities in optics [9] - The company ended 2025 with strong liquidity of approximately $1.1 billion and repurchased nearly $250 million worth of shares during the year [18][21] Q&A Session Summary Question: Thoughts on demand outlook based on PMI data - Management noted that while they were pleased with the PMI reading, they have not yet seen a corresponding inflection in demand across their businesses [34][35] Question: Insights from a new CFO's perspective - The new CFO emphasized the strength of IDEX's franchise and the focus on capital allocation to drive growth, particularly in M&A strategy [36][37] Question: Contribution of price to top line growth - Price contributed approximately 3% to overall growth in 2025, with expectations for a lower contribution in 2026 [43][44] Question: Disconnect between order strength and revenue conversion - Management explained that typical seasonal patterns and larger orders from HST are influencing the timing of revenue recognition [52][53] Question: Insights on life sciences growth - Life sciences experienced low single-digit growth, with expectations for normalization as government funding uncertainties resolve [58][59] Question: Order cadence in FMT and HST - Management indicated that sectors like energy and chemicals remain pressured, while HST is seeing strong order momentum, particularly in data centers [75][76]